SWOT Analysis for Legend Biotech Corp - ADR

Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over the Quarter (3 Months)
Turnaround Companies: Loss to Profit QoQ
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Good quarterly growth in the recent results
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter

Negative Breakdown Second Support (LTP < S2)
Stocks with Quarter Change % less than Industry
Momentum Trap (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Top Losers
Negative Breakdown First Support (LTP < S1)
Negative Breakdown Second Support (LTP < S2)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Weak Momentum: Price below Short, Medium and Long Term Averages
Top Losers